HeartSine Technologies Wins New Orders in Asia and US

HeartSine Technologies in Belfast has won new business for its cardiac defibrillators worth around £150,000 in India, Saudi Arabia and Malaysia from its participation on the Invest Northern Ireland stand at the recent Arab Health exhibition in Dubai.

The company, a pioneer in emergency cardiac technology, is supplying the HeartSine samaritan®  branded Automated External Defibrillators (AEDs) for use by clinics, emergency services and other customers in the three markets.

In addition, the US Federal Aviation Administration (FAA) in Minneapolis has recently announced its selection of Emergency University and HeartSine Technologies to provide nationwide AEDs and programme management.

It is estimated that 3,000 HeartSine AEDs will be placed in agency facilities across the US over the next five years. In addition, all FAA locations will be trained using Emergency University's Maestro Online Training programmes.

HeartSine’s engineering team in Belfast has focused on developing leading edge, innovative technology systems for portable defibrillators used in public buildings such as airports, offices and factories.

The latest deals for the company’s products were announced by Volker Brand, HeartSine’s Vice President in Europe, and welcomed by Dr Vicky Kell, Invest NI Trade Director. Arab Health 2010 was held at the end of January.

Mr Brand said: “Arab Health in Dubai was a tremendously successful show. As well as securing significant contracts for the easy-to-use defibrillators, we’ve lined up leads that are currently being followed by our sales teams worldwide. We anticipate further business resulting in time, from the high level of interest shown in our highly innovative and effective products.

“Our defibrillator has become a popular device for countering sudden cardiac arrest because it is different from any other public access defibrillator on the market. It has been designed specifically for public access use and offers ease-of-use, reliability and durability, with a seven year unit warranty, all at an inexpensive price,” he added.

Dr Kell added: “This is very encouraging news, a great boost for the company and the Invest NI team. Arab Health is now one of the most important events in our calendar of activities for local life science and biotechnology companies. It is, by far the most important exhibition and congress of its type in the Middle East and the second largest in the world.

“The exhibition has become a platform for the world’s leading manufacturers, wholesalers and distributors to meet the medical and scientific community in the Middle East and beyond, attracting over 2,000 exhibitors from 60 countries as well as 60,000 healthcare professionals who visited the event.

“This exhibition is among an extensive programme of events that we are planning to enable our companies to display their products and services. These include the BIO Conference and Exhibition in Chicago, Medica in Dusseldorf and Connected Health in Boston. In addition, companies in the sector are able to take part in our trade missions to global markets such as India and China.”